These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19130407)

  • 1. Lymph node lymphangiogenesis: a new concept for modulating tumor metastasis and inflammatory process.
    Ji RC
    Histol Histopathol; 2009 Mar; 24(3):377-84. PubMed ID: 19130407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes.
    Kitadai Y; Kodama M; Cho S; Kuroda T; Ochiumi T; Kimura S; Tanaka S; Matsumura S; Yasui W; Chayama K
    Int J Cancer; 2005 Jun; 115(3):388-92. PubMed ID: 15688374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
    Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
    Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
    Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model.
    Quagliata L; Klusmeier S; Cremers N; Pytowski B; Harvey A; Pettis RJ; Thiele W; Sleeman JP
    Clin Exp Metastasis; 2014 Mar; 31(3):351-65. PubMed ID: 24379135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
    Lee AS; Kim DH; Lee JE; Jung YJ; Kang KP; Lee S; Park SK; Kwak JY; Lee SY; Lim ST; Sung MJ; Yoon SR; Kim W
    Cancer Res; 2011 Jul; 71(13):4506-17. PubMed ID: 21586615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.
    Baluk P; Tammela T; Ator E; Lyubynska N; Achen MG; Hicklin DJ; Jeltsch M; Petrova TV; Pytowski B; Stacker SA; Ylä-Herttuala S; Jackson DG; Alitalo K; McDonald DM
    J Clin Invest; 2005 Feb; 115(2):247-57. PubMed ID: 15668734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
    Yuanming L; Feng G; Lei T; Ying W
    Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications.
    Hoshida T; Isaka N; Hagendoorn J; di Tomaso E; Chen YL; Pytowski B; Fukumura D; Padera TP; Jain RK
    Cancer Res; 2006 Aug; 66(16):8065-75. PubMed ID: 16912183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.